Heart Patients at Risk When Pharmacies Close
MONDAY, May 13, 2019 -- When pharmacies close, people with heart disease stop taking widely used heart medications, such as statins, beta-blockers, and oral anticoagulants, according to a study published online April 19 in JAMA Network Open. Dima M.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2019 Category: Pharmaceuticals Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
The effect was found only with atenolol (Tenormin). Two other beta blockers -- metoprolol (Lopressor/Toprol XL) and carvedilol (Coreg) -- did not appear to provide any protection against prostate cancer. (Source: WebMD Health)
Source: WebMD Health - May 3, 2019 Category: Consumer Health News Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
FRIDAY, May 3, 2019 -- Good news for men: That blood pressure medication you're taking might be doing double duty, helping reduce your risk of developing prostate cancer, a new study shows. Researchers found that a beta blocker called atenolol cut... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 3, 2019 Category: General Medicine Source Type: news

Adherence to CV Meds Suffers When Pharmacies Shut Down for Good Adherence to CV Meds Suffers When Pharmacies Shut Down for Good
Patients fall behind on their statins, beta blockers, and oral anticoagulants when pharmacies close, but there are opportunities for health policy, payers, and pharmacies themselves to help.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

ECG Challenge: Why Is His Pulse so Slow? ECG Challenge: Why Is His Pulse so Slow?
A man taking a beta-blocker presents with a pulse of 48 beats/min. What does his ECG show?Medscape Cardiology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2019 Category: Cardiology Tags: Cardiology Clinical Case Source Type: news

People with heart disease at risk when pharmacies close
(University of Illinois at Chicago) New research shows that when pharmacies close, people stop taking widely used heart medications -- like statins, beta-blockers and oral anticoagulants -- that have known cardiovascular and survival benefits. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2019 Category: International Medicine & Public Health Source Type: news

Clinical toxicology of beta-blocker overdose in adults - Lauterbach M.
Beta-blocker overdose is potentially harmful due to the strong blood pressure-lowering and heart rate-lowering effect. However, conflicting data exist as to their differential toxicity, single-substance exposures, and the effect of co-exposure with additio... (Source: SafetyLit)
Source: SafetyLit - March 29, 2019 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Beta Blockers (Drug Class, List of Brand and Generic Names)
Title: Beta Blockers (Drug Class, List of Brand and Generic Names)Category: MedicationsCreated: 11/24/1998 12:00:00 AMLast Editorial Review: 2/27/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 27, 2019 Category: Cardiology Source Type: news

More Young Women Are Having Heart Attacks, Study Says. This Could Be Why
Younger women are having more heart attacks, and accounted for nearly a third of all female heart attack patients in recent years, according to a recent study. The news compounds a string of recent findings that have pointed to poorer overall health for young American women. “Women now, compared to younger women generations before them, are less healthy,” says study co-author Melissa Caughey, a cardiovascular epidemiologist and instructor at the University of North Carolina Chapel Hill School of Medicine. “It’s probably reflective of poorer health in general.” The study, which appeared in a sp...
Source: TIME: Health - February 21, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Research Source Type: news

Beta blockers: Do they cause weight gain?
Yes. Weight gain can occur as a side effect of some beta blockers, especially the older ones, such as atenolol (Tenormin) and metoprolol (Lopressor, Toprol-XL). The average weight gain is about 2.6 pounds (about 1.2 kilograms). Newer beta blockers, such as carvedilol (Coreg), don't usually cause weight gain as a side effect. Weight may rise [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 19, 2019 Category: Databases & Libraries Source Type: news

Alter Ego(s) in CAD: Insights From a Recently Departed Patient Alter Ego(s) in CAD: Insights From a Recently Departed Patient
This anecdotal case presentation focuses on author Philip Roth's perhaps not-so-fictional alter-ego and his experiences with CAD and the distressing side effects of beta-blocker therapy.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Kick Health launches telemedicine prescriptions, treatment delivery service for anxiety
The startup's service will give users access to doctors who can prescribe beta-blocker propranolol.   (Source: mobihealthnews)
Source: mobihealthnews - January 24, 2019 Category: Information Technology Source Type: news

Fish living downstream from wastewater treatment plants struggle to survive exposure to manmade contaminants, medications
(Natural News) A recent study published in the journal Environmental Science and Technology revealed that exposure to pharmaceutical contaminants and pollutants — such as birth-control medication, anti-depressants, and beta blockers — may drive fishes that live downstream from a typical sewage treatment plant to exert more effort on surviving. A team of researchers at McMaster University... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Metoprolol tartrate vs. metoprolol succinate
Metoprolol tartrate and metoprolol succinate are different salt forms of metoprolol. Both drugs are beta-blockers that doctors prescribe to treat several cardiovascular conditions. However, despite being similar, they do have some different uses. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 14, 2019 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Medical News Today: All you need to know about metoprolol
Metoprolol is a beta-blocker that doctors often prescribe to treat cardiovascular issues, such as high blood pressure and angina. Different types of metoprolol have different uses. Learn more about how this drug works, when a doctor may prescribe it, and what the potential side effects can be here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 18, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

PCI in Cancer; Beta-Blocker Prophylaxis; Stress Echo Predicts Cancer Deaths
(MedPage Today) -- Updates on the latest advances in cardio-oncology (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 10, 2018 Category: Cardiology Source Type: news

Flu jab is a lifesaver for heart failure patients
Researchers from the University of Copenhagen, led by cardiologist Dr  Daniel Modin, urge for the flu jab to become part of the standard treatment for heart failure, like beta blockers. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news

Effect of preadmission beta-blockade on mortality in multiple trauma - Eriksson M, von Oelreich E, Brattstr öm O, Eriksson J, Larsson E, Oldner A.
BACKGROUND: High levels of circulating catecholamines after multiple trauma have been associated with increased morbidity and mortality. Beta-adrenergic receptor antagonist (beta-blocker) therapy has emerged as a potential treatment option, but the effect ... (Source: SafetyLit)
Source: SafetyLit - December 6, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Resumption of Beta-Blockers After Noncardiothoracic Surgery Resumption of Beta-Blockers After Noncardiothoracic Surgery
For patients taking long-term beta-blockers, what is the optimal timing for resumption following noncardiac surgery?Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

BioCardia Developing Comprehensive Approach to Treat Heart Failure
It can be a bit trick when trying to put BioCardia’s cell therapy for heart failure in one specific category. Is the CardiAmp Cell Therapy a diagnostic, device, or a biologic? Perhaps it’s all of the above. The San Carlos, CA-based company’s president and CEO painted a clearer picture for the technology noting that it could play a significant role when looking at heart failure treatment. “The [CardiAMP Cell Therapy System] is regulated by the agency [FDA] as a combination product via an IDE PMA device pathway,” Peter Altman, BioCardia...
Source: MDDI - November 16, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

Another Chance for Medtronic ’s Renal Denervation Therapy
Medtronic has yet another chance to prove its renal denervation therapy can treat uncontrolled hypertension. The Dublin-based company has received FDA approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system with patients on medication for high blood pressure. The ON MED Trial is a 2:1 randomized, sham-controlled study and will randomize up to 340 patients at 55 centers in the U.S., Japan, Europe, Australia and Canada. Patients will be followed out to three years. Primary safety endpoints will include major adverse events at one month and new renal artery stenosis at six months. The pri...
Source: MDDI - November 8, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

FDA approves Medtronic renal denervation trial in on-med patients
Medtronic (NYSE:MDT) said today that the FDA approved a clinical trial of its Symplicity Spyral renal denervation device in patients who already take medication for their high blood pressure. Fridley, Minn.-based Medtronic said the three-year, 340-patient Spyral HTN-On Med sham-controlled study is designed to compare treatment with the Symplicity Spyral device and a sham procedure, randomized on a 2:1 basis, after treatment with up to three anti-hypertensive medications, including diuretics, calcium channel blockers, ACE/ARB inhibitors and beta blockers. The primary safety endpoints include major adverse events a...
Source: Mass Device - November 8, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Featured Vascular Hypertension Medtronic Renal Source Type: news

In response to the letter to the editor: Beta blockers therapy in traumatic brain injury: is it the time to disclose the brain-cardiac interactions? - Ley EJ, Dhillon NK, Barmparas G.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - November 2, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Adulterated Supplements; Fatty Acids and Aging: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics also include include cardiovascular benefits from bariatric surgery and beta blockers in pregnancy (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 20, 2018 Category: American Health Source Type: news

Day of discharge does not influence heart surgery patient readmission rates, study finds
FINDINGSA study has found that the day of the week that a patient is discharged from the hospital does not affect the likelihood that he or she will be readmitted. The study showed comparable readmission rates for weekday and weekend or holiday discharge. It has been speculated that patients who are discharged on a weekend or holiday, when staff levels are typically lower, might be more likely to be readmitted to the hospital.The researchers found that the use before surgery of beta-blockers, a type of medication used to treat heart conditions; tobacco use; and surgical site infections were independent predictors of readmi...
Source: UCLA Newsroom: Health Sciences - October 17, 2018 Category: Universities & Medical Training Source Type: news

Beta-Blockers Carry Little Risk of Cardiac Birth Defects
(MedPage Today) -- Analysis excludes large relative, absolute risk of major malformations (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 16, 2018 Category: Cardiology Source Type: news

Hypertension medications ARE safe during pregnancy, study reveals
A new study from Brigham and Women's Hospital and Harvard Medical School has found that less than one percent of babies born to women who take beta-blockers have congenital malformations. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2018 Category: Consumer Health News Source Type: news

What Causes Hyperkalemia?
Discussion Potassium (K+) is an alkali metal (Group 1 of periodic table with Hydrogen, Lithium and Sodium) with an anatomic number of 19. Its chemical symbol K, comes from the medieval Latin, kalium which means potash (mainly potassium carbonate or potassium hydroxide), the substance it was first isolated from. Potassium is an important cation and it mainly resides in the intracellular fluid with only a small amount in the extracellular fluid. Potassium regulates cell volume, pH and enzyme functions. Hyperkalemia is defined as a potassium level> 5.5 mEq/L in children and> 6.0 mEq/L in newborns. Hyperkalemia incre...
Source: PediatricEducation.org - September 24, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Beta-Blockade After MI: No Practice Should Be Set in Stone Beta-Blockade After MI: No Practice Should Be Set in Stone
Meta-analyses suggest little benefit for beta-blockers in contemporary patients with normal ejection fraction after MI. What other dogma should be revisited in light of an evolving evidence base?theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2018 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news

AIMS: Irbesartan Slows Marfan's Aortic Dilatation, Lower BP Key? AIMS: Irbesartan Slows Marfan's Aortic Dilatation, Lower BP Key?
Also, should beta-blockers be added to angiotensin receptor blockade in Marfan syndrome? It's possible there may be synergy between the two,'but we didn't see any sign of that,'researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Beta-blocker pharmaceuticals found to be totally useless for heart attack patients... but they are routinely prescribed by doctors anyway
(Natural News) A recent study published in the Journal of the American College of Cardiology revealed that beta-blockers, a type of drug typically prescribed for heart attack, may not be as helpful in preventing the disease as previously believed. To carry out the study, a team of researchers from the University of Leeds in the U.K. pooled... (Source: NaturalNews.com)
Source: NaturalNews.com - July 30, 2018 Category: Consumer Health News Source Type: news

Mayo Clinic Q and A: How long do you need beta blockers after a heart attack?
DEAR MAYO CLINIC: How long do I need to take beta blockers after a heart attack? ANSWER: Your health care provider likely will consider a number of factors in making that decision. Guidelines recommend beta blocker therapy for three years, but that may not be necessary. Beta blockers work by blocking the effects of the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 22, 2018 Category: Databases & Libraries Source Type: news

One-third of Americans are on drugs that could make them depressed
One in three Americans are taking beta blockers, heart medications and antacids that could make them depressed, and the more they take, the worse the risks, a new University of Illinois study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2018 Category: Consumer Health News Source Type: news

200+ common medications may cause depression, study finds
New research warns depression could be a side effect of more than 200 commonly prescribed medications. They include beta-blockers for blood pressure, birth control pills, antacids and painkillers. Depression rates more than tripled when people used at least three drugs with the possible side effect, compared to people who take none of those medications. Dr. Tara Narula, a cardiologist at Northwell Health, joins "CBS This Morning" to discuss the study's findings and what patients should do if they're concerned. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 13, 2018 Category: Consumer Health News Source Type: news

Beta Blockers: Why Take a Beta Blocker?
Title: Beta Blockers: Why Take a Beta Blocker?Category: Doctor's& Expert's views on SymptomsCreated: 2/7/2005 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:04 PM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - June 13, 2018 Category: Cardiology Source Type: news

A third of Americans are on drugs that could make them depressed - and they probably don't know it
One in three Americans are taking beta blockers, heart medications and antacids that could make them depressed, and the more they take, the worse the risks, a new University of Illinois study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2018 Category: Consumer Health News Source Type: news

Are Your Meds Making You Depressed?
TUESDAY, June 12, 2018 -- Drugs taken by more than one-third of U.S. adults have depression as a possible side effect, a new study reveals. These medications include blood pressure drugs called beta-blockers, hormonal contraceptives and pain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 12, 2018 Category: General Medicine Source Type: news

Is It a Migraine? Many Patients Don ’ t Realize What Causes Their Suffering
Here ’ s a guide to help you recognize the symptoms of migraines, understand why the signs are so often missed, and think about treatment options. (Source: NYT Health)
Source: NYT Health - May 24, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Migraine Headaches Hormones Beta Blockers triptans Amgen Inc Novartis AG Source Type: news

EuroPCR 2018 Roundup: Medtronic touts BP reductions, no major adverse events in renal denervation trial
Medtronic (NYSE:MDT) today released six-month results from a trial of its Symplicity Spyral renal denervation system exploring its use treating hypertensive patients who are already taking anti-hypertension medications, touting significant reductions in blood pressure and no major adverse safety events. Results were presented at the 2018 EuroPCR annual meeting in Paris and were published in The Lancet. In the trial, patients were prescribed up to three anti-hypertensive medications, including diuretics, calcium channel blockers, ACE/ARB inhibitors or beta blockers, the Fridley, Minn.-based company said. Patients were ...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Cardiac Implants Cardiovascular Clinical Trials Abbott Medtronic ReCor Medical Source Type: news

CPAP Lowered Heart Rate in Prediabetics with Sleep Apnea
(MedPage Today) -- Magnitude of reductions in comparable to beta-blockers, researchers say (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 21, 2018 Category: Cardiology Source Type: news

Featured Review: First-line drugs for hypertension
Thiazides best first choice for hypertensionHigh blood pressure or hypertension can increase the risk of heart attacks and stroke. One of the most important decisions in treating people with elevated blood pressure is what drug class to use first. This decision has important consequences in terms of health outcomes and cost.TheCochrane Hypertension Group, which is part ofCochrane Circulation and Breathing, updated their original 2009 Cochrane Review looking at what drug class was the best first-line choice in treating adult patients with raised blood pressure. No new trials were found in the update; keeping the total at 24...
Source: Cochrane News and Events - April 20, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Research suggests alternative treatment for beta blocker intolerant heart attack patients
(New York Institute of Technology) Beta blockers have become a prescription drug staple for recovering heart attack patients. However, these blood pressure-reducing medications cannot be tolerated by many patients who are at higher risk for developing cardiovascular disease, including those with chronic obstructive pulmonary disease (COPD) and asthma, the elderly, and diabetics. As seen in the March 26 issue of Thyroid, researchers at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) now pose a new treatment for patients with beta blocker intolerance: thyroid hormone therapy. (Source: EurekAlert! -...
Source: EurekAlert! - Medicine and Health - April 10, 2018 Category: International Medicine & Public Health Source Type: news

Controlling blood pressure even when older can prevent dementia in African-Americans
(Regenstrief Institute) Controlling blood pressure with any of the commonly prescribed antihypertensive medications (beta blockers, ACE inhibitors, calcium channel blocks, and diuretics) can prevent dementia in older African-Americans with hypertension according to a new study from Regenstrief Institute researchers. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 9, 2018 Category: International Medicine & Public Health Source Type: news

Apr 6, 2018 This Week in Cardiology Apr 6, 2018 This Week in Cardiology
Beta-blockers in diabetes, ACE inhibitors vs ARBs, cardiac implantable electronic device infections, alcohol and AF, and strengthening the p value threshold are discussed in this week's podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 6, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Beta-Blockers May Be Risky With Diabetes
Beta-Blockers May Raise Mortality in People With Diabetes (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 6, 2018 Category: General Medicine Source Type: news

Beta-Blockers May Raise Mortality in People With Diabetes Beta-Blockers May Raise Mortality in People With Diabetes
Among people with CHD, study finds beta-blockers raise all-cause mortality risk in those who also have diabetes while lowering it in those withoutMedscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 5, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

ECG Challenge: Is This an Effect of AFib Treatment? ECG Challenge: Is This an Effect of AFib Treatment?
A man with atrial fibrillation, treated with a beta-blocker, undergoes a routine ECG. What does it show?Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 2, 2018 Category: Consumer Health News Tags: Cardiology Clinical Case Source Type: news

Beta Blockers vs. Valium
Title: Beta Blockers vs. ValiumCategory: MedicationsCreated: 3/29/2018 12:00:00 AMLast Editorial Review: 3/29/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 29, 2018 Category: Drugs & Pharmacology Source Type: news

When the Order Set Leads to Patient Harm (CME/CE)
(MedPage Today) -- Decision support tool pushing inappropriate beta-blocker use is case in point (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 28, 2018 Category: American Health Source Type: news